Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Prepaid Assets for 7 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 6.57% to $22.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.9 million, a 6.57% increase, with the full-year FY2025 number at $22.9 million, up 6.57% from a year prior.
  • Prepaid Assets was $22.9 million for Q4 2025 at Kymera Therapeutics, up from $22.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $22.9 million in Q4 2025 to a low of $4.8 million in Q2 2021.
  • A 5-year average of $13.3 million and a median of $12.7 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 95.93% in 2021, then rose 0.32% in 2024.
  • Kymera Therapeutics' Prepaid Assets stood at $8.7 million in 2021, then increased by 11.39% to $9.7 million in 2022, then increased by 20.19% to $11.7 million in 2023, then surged by 84.38% to $21.5 million in 2024, then increased by 6.57% to $22.9 million in 2025.
  • Per Business Quant, the three most recent readings for KYMR's Prepaid Assets are $22.9 million (Q4 2025), $22.6 million (Q3 2025), and $22.9 million (Q2 2025).